For higher-risk multiple myeloma (MM), successful patient selection and monitoring strategies are vital for the management of adverse events and the disease itself.
Researchers from the La Jolla Institute for Immunology recently used the Expanse supercomputer at the San Diego Supercomputer ...
Our immune systems develop to recognize what is foreign within our bodies. As immune cells are generated in the bone marrow ...
1d
The mammalian immune system is an evolutionary wonder. It's capable of recognizing and destroying cancer cells, and it can ...
Researchers have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against potential ...
Cells don’t just follow a rigid script when responding to stress – they’re far more adaptable than we thought. A new study ...
Conclusions: ATG1144 specifically binds to human CD24 with high sensitivity as demonstrated by IHC staining. The development and validation of the method have been finalized using Leica Bond III ...
Despite scoring a historic FDA approval last year, Adaptimmune Therapeutics is expressing concerns about its own longevity, ...
The Lupus Research Alliance (LRA) is proud to announce the inaugural recipients of the new Targeted Research Program on ...
Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...
Seismic Therapeutic, Inc., the machine learning immunology company, today announced the formation of a Translational Medicine Advisory Board to support the company's focus on accelerating the path to ...
AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback